ArticleZeitschrift fur Rheumatologie2013
[Comorbidities in psoriatic arthritis].
Article in Zeitschrift fur Rheumatologie, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 4 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Psoriatic arthritis occurs almost exclusively together with psoriasis (of the skin). Thus, psoriasis-associated diseases or comorbidities are also seen in psoriatic arthritis patients. Among the clinically most relevant comorbidities are cardiovascular diseases and their risk factors, namely smoking, obesity and the metabolic syndrome. Moreover, psychological conditions and osteoporosis should also be considered. The link between psoriasis, psoriatic arthritis and its comorbidities has been established based on epidemiological studies; however, at least for the cardiovascular comorbidities, the association can be explained based on novel insights into the pathogenesis of atherosclerosis. For the practising physician it is important to take into account the aspect of comorbidity to come to an optimal treatment decision in each individual case. Clinical decision-making is complicated further by the fact that comorbidity necessitates comedication which again influence the choice of treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.